Biocompatible Membrane Composite for Immune Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable devices face challenges in maintaining the viability of encapsulated bioactive entities due to the formation of foreign body giant cells, which hinder the formation of blood vessels near the cell impermeable interface, restricting access to oxygen and nutrients.
Innovation Solution
A biocompatible membrane composite with a first layer having a maximum pore size less than 1 micron and a second layer with bonded solid features spaced less than 50 microns, providing immune isolation while mitigating the foreign body response to facilitate vascularization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a cell impermeable membrane is used to isolate encapsulated cells from the host immune system, then immune isolation is achieved, but foreign body giant cells form and prevent blood vessel formation near the interface
Solution Approach 1:
A mitigation layer is introduced as an intermediary component between the cell impermeable membrane and the host tissue. This mitigation layer has controlled porosity and structural features that prevent foreign body giant cell formation while allowing the cell impermeable membrane to maintain its immune isolation function. The mitigation layer acts as a mediator that resolves the conflict between immune isolation and foreign body response.
Solution Approach 2:
The device uses a composite structure consisting of a cell impermeable membrane layer and a mitigation layer with different properties. The cell impermeable membrane provides immune isolation, while the mitigation layer provides a biocompatible interface that promotes vascularization. This composite approach allows both functions to coexist without interference.
2Reliability
If the membrane pore size is reduced to prevent cell passage, then cell encapsulation is maintained, but nutrient and oxygen diffusion to encapsulated cells is restricted
Solution Approach 1:
The solution moves the vascularization interface from the cell impermeable membrane side to the mitigation layer side. Blood vessels form in the mitigation layer rather than attempting to penetrate the cell impermeable membrane, creating a new spatial dimension for nutrient delivery that bypasses the pore size limitation.
Solution Approach 2:
The device is segmented into distinct functional layers: a cell impermeable membrane for encapsulation and a porous mitigation layer for vascularization. This segmentation allows each layer to optimize its specific function without compromising the other.
3Strength
If a thick membrane is used to provide structural support and immune isolation, then device integrity is maintained, but the diffusion distance for oxygen and nutrients to reach encapsulated cells increases
Solution Approach 1:
The solution creates a new spatial dimension by forming blood vessels in the mitigation layer adjacent to the cell impermeable membrane. This reduces the effective diffusion distance from the thick membrane scenario to a thin interface region, while the thick membrane structure is maintained for structural support.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The membrane composite supports the survival of encapsulated cells by reducing foreign body giant cell formation, enabling sufficient vascularization and nutrient access, thereby enhancing the viability and therapeutic efficacy of implanted cells.
Implementation Method 1
biocompatible materials that permit the passage of nutrients through but prevent the passage of the cells encapsulated therethrough
Implementation Method 2
diffusion distance and time needed for transport of the oxygen and nutrients to the implanted, encapsulated cells
Implementation Method 3
provides the encapsulated cells sufficient immune isolation from the host's immune cells while providing an environment that is able to mitigate or tailor the foreign body response such that sufficient blood vessels are able to form at a cell impermeable interface
Data Source
Figure 1A~1B
Figure 2
Figure 3A~3B
AI summary
A biocompatible membrane composite including a cell impermeable layer and a mitigation layer is provided. The cell impermeable layer is impervious to vascular ingrowth and prevents cellular contact from the host. Additionally, the mitigation layer includes solid features. In at least one embodiment, mitigation layer has therein bonded solid features. In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded or otherwise connected to each other to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned external to or within the biocompatible membrane composite to provide support to and prevent distortion. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.